皇冠hg156体育下载地址

Carol Gallagher, Pharm.D.

Venture Partner, Menlo Park

Photo of Carol Gallagher, Pharm.D.

皇冠hg156体育下载地址carol gallagher joined nea in october, 2014. she is primarily focused on making biopharma investments. carol is a proven entrepreneur, operator and more recently investor with nearly 30 years of experience in commercial, drug development and business development roles. prior to joining nea she was a venture partner with frazier healthcare and she served as an independent director on multiple boards. from 2008-2011, carol was president and ceo of calistoga pharmaceuticals which developed the first-in-class therapeutic now marketed by gilead as zydelig.

皇冠hg156体育下载地址she currently serves as chairman of millendo and as a director at atarabio, annexon, chromacode, metacrine, pionyr immunotherapeutics, qpex biopharma, and turning point therapeutics.

Companies